These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11102738)

  • 21. Phenobarbital population pharmacokinetics across the pediatric age spectrum.
    Moffett BS; Weingarten MM; Galati M; Placencia JL; Rodman EA; Riviello JJ; Kayyal SY
    Epilepsia; 2018 Jul; 59(7):1327-1333. PubMed ID: 29897629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cytochrome P450 (CYP)2C19 polymorphisms on pharmacokinetics of phenobarbital in neonates and infants with seizures.
    Lee SM; Chung JY; Lee YM; Park MS; Namgung R; Park KI; Lee C
    Arch Dis Child; 2012 Jun; 97(6):569-72. PubMed ID: 22331680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenobarbital in intensive care unit pediatric population: predictive performances of population pharmacokinetic model.
    Marsot A; Michel F; Chasseloup E; Paut O; Guilhaumou R; Blin O
    Fundam Clin Pharmacol; 2017 Oct; 31(5):558-566. PubMed ID: 28407406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenobarbital reduces EEG amplitude and propagation of neonatal seizures but does not alter performance of automated seizure detection.
    Mathieson SR; Livingstone V; Low E; Pressler R; Rennie JM; Boylan GB
    Clin Neurophysiol; 2016 Oct; 127(10):3343-50. PubMed ID: 27514722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures.
    van den Broek MP; Huitema AD; van Hasselt JG; Groenendaal F; Toet MC; Egberts TC; de Vries LS; Rademaker CM
    Clin Pharmacokinet; 2011 Jul; 50(7):461-9. PubMed ID: 21651313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenytoin and phenobarbital stable isotope studies in neonates.
    Malik SI; Painter MJ; Venkataramanan R; Alvin JD
    Pediatr Neurol; 2003 Nov; 29(5):376-80. PubMed ID: 14684232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of co-medication on the pharmacokinetic parameters of phenobarbital in asphyxiated newborns.
    Šíma M; Pokorná P; Hronová K; Slanař O
    Physiol Res; 2015; 64(Suppl 4):S513-9. PubMed ID: 26681081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenobarbital for Neonatal Seizures: A Time for Perusal.
    Jain P; Sankhyan N
    Indian Pediatr; 2016 May; 53(5):381-2. PubMed ID: 27254043
    [No Abstract]   [Full Text] [Related]  

  • 29. Phenobarbital pharmacokinetics in neonates.
    Pitlick W; Painter M; Pippenger C
    Clin Pharmacol Ther; 1978 Mar; 23(3):346-50. PubMed ID: 627141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions.
    Kokwaro GO; Ogutu BR; Muchohi SN; Otieno GO; Newton CR
    Br J Clin Pharmacol; 2003 Oct; 56(4):453-7. PubMed ID: 12968992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of phenobarbital in dogs after multiple oral administration.
    Ravis WR; Nachreiner RF; Pedersoli WM; Houghton NS
    Am J Vet Res; 1984 Jul; 45(7):1283-6. PubMed ID: 24049884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antenatal phenobarbital therapy and neonatal outcome. I: Effect on intracranial hemorrhage.
    Shankaran S; Cepeda E; Muran G; Mariona F; Johnson S; Kazzi SN; Poland R; Bedard MP
    Pediatrics; 1996 May; 97(5):644-8. PubMed ID: 8628600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of a drug-drug interaction on population-based phenobarbitone clearance using nonlinear mixed-effects modeling.
    Yukawa E; To H; Ohdo S; Higuchi S; Aoyama T
    Eur J Clin Pharmacol; 1998 Mar; 54(1):69-74. PubMed ID: 9591934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
    Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
    Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data.
    Grasela TH; Donn SM
    Dev Pharmacol Ther; 1985; 8(6):374-83. PubMed ID: 4075936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of phenobarbital-carbamazepine-valproic acid interactions using population pharmacokinetic analysis for optimisation of antiepileptic drug therapy: an overview.
    Yukawa E
    Drug Metabol Drug Interact; 2000; 16(2):86-98. PubMed ID: 10962642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenobarbital for neonatal seizures in hypoxic ischemic encephalopathy: a pharmacokinetic study during whole body hypothermia.
    Filippi L; la Marca G; Cavallaro G; Fiorini P; Favelli F; Malvagia S; Donzelli G; Guerrini R
    Epilepsia; 2011 Apr; 52(4):794-801. PubMed ID: 21371018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic variability of phenobarbital: a systematic review of population pharmacokinetic analysis.
    Methaneethorn J; Leelakanok N
    Eur J Clin Pharmacol; 2021 Mar; 77(3):291-309. PubMed ID: 33078242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of carbamazepine drug interaction by multiple peak approach screening using routine clinical pharmacokinetic data.
    Yukawa E; Aoyama T
    J Clin Pharmacol; 1996 Aug; 36(8):752-9. PubMed ID: 8877681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.